News
Presentation Details Title: Liver-Targeted KAN-101 Induces Gliadin-Specific Immune Tolerance in Celiac Disease: Safety, Tolerability, and Pharmacodynamic Assessments of a Phase 1 Trial Date & Time ...
The Top 25 Firm plans to launch a data warehouse service for smaller organizations this year and has been using AI to develop ...
For these reasons, insights as a service is emerging as the next big wave in business intelligence. According to author Randy Bean, “Organizations that successfully shift from selling data to ...
Details of the presentation are as follows: Title and Link: Phase 1 Clinical Trial Evaluating TTI-101, a First-in-Class, Orally Bioavailable, Small Molecule, Inhibitor of STAT3, in Patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results